{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-003611","form_type":"8-K","ticker":"NDRA","cik":"0001681682","company_name":"ENDRA Life Sciences Inc.","filed_at":"2025-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.425694+00:00","generated_at":"2026-05-24T01:55:27.536393+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ENDRA Life Sciences Q4 net loss $4.2M, cash burn cut, pivots to GLP-1 metabolic health","bullets":["Q4 2024 net loss $4.2M ($1.5M in Q4 2023) includes $2.3M non-cash inventory charge; full-year net loss $11.5M.","Cash used in operations Q4 2024 $1.5M, down 32% YoY; expects ~$0.35M/month burn in Q2/Q3 2025.","Cash and equivalents $3.2M at Dec 31, 2024; prior to pivot, runway limited given burn rate.","New strategic direction: TAEUS as biomarker for monitoring GLP-1 drug patients, targeting pharma, concierge, primary care.","Planned De Novo pivotal trial: multi-center, ~250 subjects, hypothesis-driven, with FDA pre-submission alignment."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-003611","json":"https://secwatch.observer/filing/0001654954-25-003611.json","markdown":"https://secwatch.observer/filing/0001654954-25-003611.md","text":"https://secwatch.observer/filing/0001654954-25-003611.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681682/000165495425003611/0001654954-25-003611-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681682/000165495425003611/endra_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T01:55:27.536393+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}